Attached files
| file | filename |
|---|---|
| 8-K - FORM 8-K - Q Therapeutics, Inc. | v237419_8k.htm |
| EX-2.1 - EXHIBIT 2.1 - Q Therapeutics, Inc. | v237419_ex2-1.htm |
| EX-99.2 - EXHIBIT 99.2 - Q Therapeutics, Inc. | v237419_ex99-2.htm |
| EX-10.1 - EXHIBIT 10.1 - Q Therapeutics, Inc. | v237419_ex10-1.htm |
| EX-99.1 - EXHIBIT 99.1 - Q Therapeutics, Inc. | v237419_ex99-1.htm |
| EX-10.3 - EXHIBIT 10.3 - Q Therapeutics, Inc. | v237419_ex10-3.htm |
| EX-99.3 - EXHIBIT 99.3 - Q Therapeutics, Inc. | v237419_ex99-3.htm |
| EX-10.2 - EXHIBIT 10.2 - Q Therapeutics, Inc. | v237419_ex10-2.htm |
W. T. UNIACK & CO. CPA’S, P.C.
CERTIFIED PUBLIC ACCOUNTANTS
Licensed in Georgia and Ohio
|
1003 Weatherstone Pkwy., Ste. 320
|
12600 Deerfield Pkwy., Ste 100
|
|
|
Woodstock, GA 30188
|
Alpharetta, GA 30004
|
|
|
Phone: 770-592-3233
|
Phone: 678-773-0251
|
October 14, 2011
U.S. Securities and Exchange Commission
100 F Street NE
Washington D.C. 20549
|
Re:
|
Grace 2, Inc.
|
Commission File No. 000-52062
Dear Sir/Madam:
We have read the statements set forth by Grace 2, Inc. (the “Company”) in Item 4.01(a) regarding the dismissal of W.T. Uniack & Co. CPA’s P.C., on October 13, 2011, as the Company’s independent registered public accounting firm. These statements are being filed with the U.S. Securities and Exchange Commission in the Company’s current report on Form 8-K, and we are in agreement with the statements contained therein.
Very truly yours,
/s/ W.T. Uniack & Co. CPA’s P.C.
WOODSTOCK, GEORGIA
October 14, 2011